Article Text

Download PDFPDF
Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting
  1. M Preusser1,
  2. T Ströbel1,
  3. E Gelpi1,2,
  4. M Eiler3,
  5. G Broessner4,
  6. E Schmutzhard4,
  7. H Budka1,2
  1. 1Institute of Neurology, Medical University Vienna, Austria
  2. 2Austrian Reference Centre for Human Prion Diseases (OERPE), General Hospital Vienna, Austria
  3. 3Department of Neurology, LKH Rankweil, Austria
  4. 4Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
  1. Correspondence to:
 Dr H Budka
 Institute of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 4J, 1097 Vienna, Austria; herbert.budka{at}


We report the case of a 28 year old man who had received a cadaverous dura mater graft after a traumatic open skull fracture with tearing of the dura at the age of 5 years. A clinical suspicion of Creutzfeldt-Jakob disease (CJD) was confirmed by a brain biopsy 5 months prior to death and by autopsy, thus warranting the diagnosis of iatrogenic CJD (iCJD) according to WHO criteria. Immunohistochemistry showed widespread cortical depositions of disease associated prion protein (PrPsc) in a synaptic pattern, and western blot analysis identified PrPsc of type 2A according to Parchi et al. Surprisingly, we found Alzheimer-type senile plaques and cerebral amyloid angiopathy in widespread areas of the brain. Plaque-type and vascular amyloid was immunohistochemically identified as deposits of beta-A4 peptide. CERAD criteria for diagnosis of definite Alzheimer’s disease (AD) were met in the absence of neurofibrillar tangles or alpha-synuclein immunoreactive inclusions. There was no family history of AD, CJD, or any other neurological disease, and genetic analysis showed no disease specific mutations of the prion protein, presenilin 1 and 2, or amyloid precursor protein genes. This case represents (a) the iCJD case with the longest incubation time after dural grafting reported so far, (b) the youngest documented patient with concomitant CJD and Alzheimer-type neuropathology to date, (c) the first description of Alzheimer-type changes in iCJD, and (d) the second case of iCJD in Austria. Despite the young patient age, the Alzheimer-type changes may be an incidental finding, possibly related to the childhood trauma.

  • AD, Alzheimer’s disease
  • BA, beta-amyloid
  • CERAD, Consortium to Establish a Registry for Alzheimer’s Disease
  • CJD, Creutzfeldt-Jakob disease
  • CSF, cerebrospinal fluid
  • iCJD, iatrogenic Creutzfeldt-Jakob disease
  • Alzheimers disease
  • trauma
  • iatrogenic Creutzfeldt-Jakob disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: none